Cargando…
Busulphan-Cyclophosphamide Cause Endothelial Injury, Remodeling of Resistance Arteries and Enhanced Expression of Endothelial Nitric Oxide Synthase
Stem cell transplantation (SCT) is a curative treatment for malignant and non malignant diseases. However, transplantation-related complications including cardiovascular disease deteriorate the clinical outcome and quality of life. We have investigated the acute effects of conditioning regimen on th...
Autores principales: | Al-Hashmi, Sulaiman, Boels, Piet J. M., Zadjali, Fahad, Sadeghi, Behnam, Sällström, Johan, Hultenby, Kjell, Hassan, Zuzana, Arner, Anders, Hassan, Moustapha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267746/ https://www.ncbi.nlm.nih.gov/pubmed/22303468 http://dx.doi.org/10.1371/journal.pone.0030897 |
Ejemplares similares
-
The Effect of Cysteine on the Immunosuppressive Activity of Busulphan, Cyclophosphamide and Nitrogen Mustard
por: Addison, I. E., et al.
Publicado: (1971) -
Reduced lethality in mice receiving a combined dose of cyclophosphamide and busulphan.
por: Millar, J. L., et al.
Publicado: (1975) -
Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway
por: El-Serafi, Ibrahim, et al.
Publicado: (2017) -
Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging
por: Asem, Heba, et al.
Publicado: (2016) -
Essential thrombocythemia: Busulphan revisited
por: Koduri, Prasad R.
Publicado: (2016)